Paul Govern Archive — Page 31 of 54
-
October 3, 2019
Diabetes drug study explores cardiovascular risks for patients with kidney disease
An observational study using medical record information from nearly 50,000 U.S. military veterans sheds new light on which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease. -
October 2, 2019
Research team sorts out drug screen false positive results
Vanderbilt investigators have identified 13 previously unknown drug compounds that cause false positive screenings for amphetamines, buprenorphine (an opioid), cannabinoids and methadone. -
September 25, 2019
Study to explore care coordination’s impact on patient outcomes
You Chen, PhD, has been awarded a four-year, $1.5 million research grant to study care coordination patterns and their influence on hospital length of stay and unplanned patient readmission. -
September 24, 2019
Treating C. diff: new purpose for an old drug?
An inexpensive generic drug once used to prevent gastrointestinal ulcers in people taking daily NSAIDs protects against C. diff infection in mice. -
September 19, 2019
VUMC’s Blume honored by the University of Amsterdam
The University of Amsterdam has awarded the 2019 Spinoza Chair in medicine to Jeffrey Blume, PhD, associate professor of Biostatistics and Biomedical Informatics at VUMC. -
September 19, 2019
Security software required for employees’ smartphones, tablets
To help prevent unauthorized data access, Vanderbilt University Medical Center is requiring employees who use their personal smartphones and digital tablets to conduct VUMC business to enroll in mobile device management by Feb. 1, 2020.